Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.

Condition:   Malaria Interventions:   Biological: PfSPZ Vaccine;   Biological: PfSPZ Challenge (for CHMI);   Other: Normal Saline;   Biological: PfSPZ Challenge (for PfSPZ-CVac) Sponsors:   Sanaria Inc.;   Ifakara Health Institute;   Swiss Tropical & Public Health Institute;   Government of Equatorial Guinea;   Marathon Oil Corporation;   Noble Oil Services;   La Paz Medical Center, Malabo, Equatorial Guinea Not yet recruiting - verified August 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials